Oxlumo®

OXLUMO® is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Manufacturer:

Alnylam Pharmaceuticals, Inc

Class:

Gene Therapy

What It Treats:

Primary Hyperoxaluria Type 1

PRESCRIBED BY:

Nephrologists

HOW ADMINISTERED:

Subcutaneous Injection

FREQUENCY:

Monthly

Length of infusion:

N/A

RELATED DRUGS: